HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Description

This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal is to encourage initial translational efforts that will support a drug discovery program and advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program. The scope will therefore be focused on development of assays to support a distinct testing funnel, screening efforts to identify hits, and initial characterization of hits and potential therapeutic agents (including small molecules, biologics, and natural products).

Official source

Eligible beneficiaries

• Special district governments
• Public and State controlled institutions of higher education
• For profit organizations other than small businesses
• State governments
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Small businesses
• County governments
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Private institutions of higher education
• Native American tribal governments (Federally recognized)
• Independent school districts
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Public housing authorities/Indian housing authorities
• Native American tribal organizations (other than Federally recognized tribal governments)
• City or township governments